Trial Profile
Pharmacokinetics studies in women of 2 novel oral formulations of tranexamic acid therapy for heavy menstrual bleeding.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2011
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Menorrhagia
- Focus Therapeutic Use
- Sponsors Celerion; Xanodyne Pharmaceuticals
- 28 Mar 2011 New trial record